Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1136375

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which NHS trusts offer immunotherapy; and for which (a) indications and (b) ages of patient.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	272294
answer	answer is ministerial correction date of answer 08/07/2019 answer text <p>The following centres are able to provide chimeric antigen receptor T-cell (CAR-T) therapy for acute lymphoblastic leukaemia for children and young people up to the age of 25:</p><p>- Great Ormond Street Hospital;</p><p>- University College London Hospital;</p><p>- King’s College Hospital;</p><p>- University Hospitals Bristol NHS Trust;</p><p>- The Christie NHS Foundation Trust;</p><p>- Manchester Royal Infirmary;</p><p>- Royal Manchester Children’s Hospital;</p><p>- Queen Elizabeth Hospital (Birmingham); and</p><p>- Great Northern Children’s Hospital (Newcastle).</p><p>The following centres are able to provide CAR-T for adults with large B-cell lymphoma:</p><p>- University College London Hospital;</p><p>- King’s College Hospital;</p><p>- University Hospitals Bristol NHS Trust;</p><p>- The Christie NHS Foundation Trust;</p><p>- Manchester Royal Infirmary;</p><p>- Queen Elizabeth Hospital Birmingham; and</p><p>- Newcastle Hospitals NHS Foundation Trust.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/07/2019 15:37:29 answering member 4455 label Biography information for Seema Kennedy
tabling member	4657 label Biography information for Anneliese Dodds

1136376

registered interest
date	02/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the availability of immunotherapy.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	272295
answer	answer is ministerial correction date of answer 08/07/2019 answer text <p>When an immunotherapy treatment has been approved by the National Institute for Health and Care Excellence (NICE), all relevant providers are required to implement NICE’s guidance and make the treatment available for patients on the National Health Service.</p><p>The NHS Long Term Plan sets out our commitment to making safer and more precise treatments, including advanced radiotherapy techniques and immunotherapies, available on the NHS to support improvements in survival rates.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/07/2019 16:11:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	4657 label Biography information for Anneliese Dodds